Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosed with type 1 diabetes mellitus for at least 24 months~* usage of daily insulin treatment~* random serum C-peptide concentration \< 0.5 ng/mL~Exclusion Criteria:~* pregnant or nursing~* HbA1c \>9.0%~* renal insufficiency~* hepatic synthetic insufficiency~* aspartate or alanine aminotransferase \> 3 times the upper limit of normal~* hematocrit less than or equal to 30%~* use of \> 2.0 U/kg total insulin dose per day~* inadequate bilateral venous access in both arms~* congestive heart failure, New York Heart Association class II, III or IV~* active malignancy within 5 years, except basal cell or squamous cell skin cancers~* history of breast cancer or malignant melanoma~* major surgical operation within 30 days~* current seizure disorder.~* current bleeding disorder, treatment with warfarin, or platelet count below 50,000~* history of pheochromocytoma or disorder with increased risk of pheochromocytoma~* history of insulinoma~* history of glycogen storage disease.~* positive for HIV, hepatitis C virus or active hepatitis B virus infection~* whole blood donation of 1 pint (500 mL) within 8 weeks~* active substance or alcohol abuse~* administration of glucagon within 28 days~* participation in other studies involving an investigational drug or device within 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- G-Pen first, then Lilly Glucagon (Type: OTHER): A single 1 mg subcutaneous (SC) injection of G-Pen (glucagon injection) with a 7-28 day wash-out, followed by a single 1 mg SC injection of Lilly Glucagon (glucagon injection \[rDNA origin\])
- Lilly Glucagon first, then G-Pen (Type: OTHER): A single 1 mg SC injection of Lilly Glucagon (glucagon injection \[rDNA origin\]) with a 7-28 day wash-out, followed by a single 1 mg SC injection of G-Pen (glucagon injection)

Based on this trial design, predict the completion outcome and termination type (if applicable).